Belgian molecular Dx company obtains $7.3 million

02/15/2013 | GenomeWeb Daily News (free registration)

A funding round has pulled in $7.3 million for Multiplicom, a Belgian firm that develops research-use-only test kits for muscle disease, cystic fibrosis, kidney disease, heart failure and bowel cancer. The company will use the money to further develop its molecular diagnostic tests and expand its sales channels in Europe.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Abbott
Santa Ana, CA